We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current TTALF market cap is 1.64B. The company's latest EPS is EUR -0.3335 and P/E is -38.83.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 1.03B | 989.1M | 1.16B | 1.26B | 1.29B |
| Operating Income | 80.9M | 66.5M | 109.5M | 33.9M | -14.9M |
| Net Income | 54M | 45.8M | 80.4M | 24.4M | -42.2M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 1.36B | 1.36B | 1.45B | 1.48B | 1.42B |
| Total Liabilities | 818.1M | 789.6M | 839.7M | 887.4M | 904.1M |
| Total Equity | 541.2M | 571.4M | 608.9M | 592M | 515.4M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 173.6M | 143.7M | 195.2M | 141M | 158M |
| Investing | -46.7M | -36M | -108M | -94M | -44.2M |
| Financing | -123.1M | -71.2M | -126.1M | -44.6M | -116.2M |
| Market Cap | 1.64B |
| Price to Earnings Ratio | -38.83 |
| Price to Sales Ratio | 1.27 |
| Price to Cash Ratio | 43.47 |
| Price to Book Ratio | 3.18 |
| Dividend Yield | - |
| Shares Outstanding | 126.55M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 1 (9.62%) |
| Company Name | Terveystalo Oy (PK) |
| Address |
jaakonkatu 3 b helsinki FI-00100 |
| Website | https://www.terveystalo.com/en |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
